Compound Summary
Compound Information
carbamazepine
Compound Name: | carbamazepine |
Compound CID: | 2554 |
Synonyms: | carbamazepine 298-46-4 Tegretol Carbamazepen 5H-Dibenzob,fazepine-5-carboxamide More... |
Iupac Name: | benzo[b][1]benzazepine-11-carboxamide |
InChI: | InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18) |
InChIKey: | FFGPTBGBLSHEPO-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N |
Isomeric Smiles: | C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N |
Molecular Weight: | 236.27 |
Molecular Formula: | C15H12N2O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
carbamazepine
Molecular Weight: | 236.27 |
Molecular Formula: | C15H12N2O |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 18 |
Complexity: | 326 |
Synonyms
carbamazepine
| carbamazepine | carbamazepine |
|---|---|
carbamazepine |
298-46-4 |
Tegretol |
Carbamazepen |
5H-Dibenzob,fazepine-5-carboxamide |
Carbazepine |
Finlepsin |
Biston |
Equetro |
5H-Dibenzb,fazepine-5-carboxamide |
Carbamezepine |
Tegretal |
Epitol |
Carbatrol |
Neurotol |
Timonil |
Carbamazepin |
Karbamazepin |
Stazepine |
Telesmin |
Lexin |
Tegretol-Xr |
benzob1benzazepine-11-carboxamide |
5H-Dibenz(b,f)azepine-5-carboxamide |
Carbamazepina |
Carbamazepinum |
Amizepin |
Bipotrol |
Teril |
Geigy 32883 |
5-Carbamyl-5H-dibenzo(b,f)azepine |
5-Carbamoyl-5H-dibenzo(b,f)azepine |
Calepsin |
Carnexiv |
5-Carbamoyl-5H-dibenz(b,f)azepine |
5-Carbamoyl-5H-dibenzb,fazepine |
G 32883 |
G-32883 |
NSC 169864 |
MFCD00005073 |
CHEBI:3387 |
UNII-33CM23913M |
CHEMBL108 |
5-Carbamyldibenzo(b,f)azepine |
MLS000069652 |
5-Carbamoyldibenzo(b,f)azepine |
CBZ |
dibenzob,fazepine-5-carboxamide |
NSC169864 |
33CM23913M |
NSC-169864 |
NCGC00015234-11 |
CAS-298-46-4 |
SMR000058201 |
Stazepin |
DSSTox_CID_2731 |
2-azatricyclo9.4.0.0^{3,8}pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide |
DSSTox_RID_76704 |
DSSTox_GSID_22731 |
5H-dibenzob,fazepine-5-carboxamide;Oxcarbazepine IMpurity A |
Carbelan |
Sirtal |
Tegretol Cr |
Carbamazepinum INN-Latin |
Carbamazepina INN-Spanish |
SMR001227191 |
HSDB 3019 |
SR-01000000229 |
Carbatrol extended-release |
EINECS 206-062-7 |
BRN 1246090 |
Trimonil |
Neurotop retard |
Tegretol (TN) |
Prestwick_104 |
Equetro (TN) |
Carbamazepine-d2 |
Carbamazepine, powder |
1173022-00-8 |
Opera_ID_72 |
Spectrum_000096 |
Carbamazepine USAN:USP:INN:BAN:JAN |
Prestwick0_000052 |
Prestwick1_000052 |
Prestwick2_000052 |
Prestwick3_000052 |
Spectrum2_000125 |
Spectrum3_000325 |
Spectrum4_000262 |
Spectrum5_000936 |
Carbamazepine (Carbatrol) |
Lopac-C-4024 |
ChemDiv1_018966 |
CBChromo1_000350 |
Epitope ID:174842 |
Iminostilbene-N-carboxamide |
Carbamazepine-13C,15N |
Lopac0_000292 |
Oprea1_790775 |
SCHEMBL21639 |
BSPBio_000203 |
BSPBio_001929 |
KBioGR_000724 |
KBioSS_000516 |
MLS001055475 |
MLS001074172 |
MLS002548877 |
BIDD:GT0479 |
DivK1c_000388 |
DivK1c_003750 |
SPECTRUM1500159 |
SPBio_000170 |
SPBio_002124 |
BPBio1_000225 |
GTPL5339 |
ZINC4785 |
DTXSID4022731 |
SCHEMBL19838283 |
HMS501D10 |
HMS640O02 |
KBio1_000388 |
KBio2_000516 |
KBio2_003084 |
KBio2_005652 |
KBio3_001149 |
WLN: T C676 BNJ BVZ |
AOB5783 |
Carbamazepine (JP17/USP/INN) |
CBZ;NSC 169864 |
dibenzb,fazepine-5-carboxamide |
SPD-417 |
Carbamazepine, analytical standard |
NINDS_000388 |
HMS1568K05 |
HMS1920I17 |
HMS2090M07 |
HMS2091O19 |
HMS2095K05 |
HMS2233G16 |
HMS3039K09 |
HMS3259B21 |
HMS3260L06 |
HMS3372J13 |
HMS3657G03 |
HMS3712K05 |
HMS3747E03 |
Pharmakon1600-01500159 |
ACT02606 |
BCP21380 |
HY-B0246 |
5-Carbomoyl-5H-dibenzo(b,f)azepine |
Tox21_110104 |
Tox21_202273 |
Tox21_300195 |
Tox21_500292 |
AC2074 |
BBL005372 |
BDBM50003659 |
CCG-38931 |
NSC755920 |
s1693 |
STK177357 |
STL453548 |
11-benzob1benzazepinecarboxamide |
5H-Dibenzb,fazepine-5-carboxamine |
Carbamazepine 1.0 mg/ml in Methanol |
AKOS003235644 |
AKOS025397243 |
Tox21_110104_1 |
AC-9538 |
DB00564 |
KS-5146 |
LP00292 |
MCULE-9121567287 |
NC00679 |
NSC-755920 |
SDCCGSBI-0050280.P005 |
5H-Dibenz b, fazepine-5-carboxamide |
CDS1_002710 |
IDI1_000388 |
5H-Dibenzob,fazepine-5-carboxamide # |
NCGC00015234-01 |
NCGC00015234-02 |
NCGC00015234-03 |
NCGC00015234-04 |
NCGC00015234-05 |
NCGC00015234-06 |
NCGC00015234-07 |
NCGC00015234-08 |
NCGC00015234-09 |
NCGC00015234-10 |
NCGC00015234-12 |
NCGC00015234-13 |
NCGC00015234-14 |
NCGC00015234-15 |
NCGC00015234-16 |
NCGC00015234-18 |
NCGC00015234-19 |
NCGC00015234-33 |
NCGC00023877-03 |
NCGC00023877-04 |
NCGC00023877-05 |
NCGC00023877-06 |
NCGC00023877-07 |
NCGC00023877-08 |
NCGC00253982-01 |
NCGC00259822-01 |
NCGC00260977-01 |
BC166161 |
H495 |
ST075773 |
SY002823 |
(z)-5h-dibenzob,fazepine-5-carboxamide |
SBI-0050280.P004 |
5H-dibenzob,fazepine-5-carboximidic acid |
AB0070254 |
DB-047659 |
Dibenzob,fazepine-5-carboxylic acid amide |
EU-0100292 |
FT-0602927 |
FT-0696814 |
SW220141-1 |
BIM-0050280.0001 |
C 4024 |
C06868 |
Carbamazepine, meets USP testing specifications |
D00252 |
5H-Dibenz(b,f)azepine-5-carboxamide maleic acid |
5H-Dibenz(b,f)azepine-5-carboxamide oxalic acid |
AB00051931-17 |
AB00051931-18 |
AB00051931_19 |
AB00051931_20 |
A820074 |
Q410412 |
carbamazepine host structure with maleic acid removed |
carbamazepine host structure with oxalic acid removed |
Q-200792 |
SR-01000000229-2 |
SR-01000000229-4 |
SR-01000000229-7 |
5H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acid |
BRD-K71799949-001-06-7 |
F0348-2551 |
Z2199879032 |
carbamazepine host structure with DL-tartaric acid removed |
Dibenzob,fazepine-5-carboxylic acid amide(Carbamazepine) |
carbamazepine host structure with 4-hydroxybenzoic acid removed |
Carbamazepine, British Pharmacopoeia (BP) Reference Standard |
Carbamazepine, European Pharmacopoeia (EP) Reference Standard |
Carbamazepine, United States Pharmacopeia (USP) Reference Standard |
Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material |
N6W |
Experimental Data
carbamazepine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 2 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
carbamazepine
Statistics Data
carbamazepine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 2 | 1 | 1 |
Statistics Data Visualization
carbamazepine
